CLGM
ROIV icon

Capitolis Liquid Global Markets’s Roivant Sciences ROIV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.39M Sell
237,000
-488,000
-67% -$14.4M 0.04% 205
2026
Q1 		$20.1M Buy
725,000
+554,200
+324% +$14.2M 0.13% 131
2025
Q4 		$3.71M Buy
+170,800
New +$3.37M 0.02% 248

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Capitolis Liquid Global Markets's ROIV Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its Roivant Sciences (ROIV) stake by 67% in Q2 2026, selling an estimated $14.4M and leaving 237,000 shares worth $8.39M. The position accounts for 0.04% of the portfolio, ranked #205.

Capitolis Liquid Global Markets first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.1M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Capitolis Liquid Global Markets held 237,000 shares of Roivant Sciences worth $8.39M as of Q2 2026.
  • Capitolis Liquid Global Markets sold 488,000 Roivant Sciences shares in Q2 2026, an estimated $14.4M.
  • Roivant Sciences made up 0.04% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #205 holding.
  • Capitolis Liquid Global Markets first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • Capitolis Liquid Global Markets's Roivant Sciences position peaked at $20.1M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.